Dr. Bradley Vilims, MD

NPI: 1881664944
Total Payments
$962,328
2024 Payments
$90,589
Companies
6
Transactions
44

Payment Breakdown by Category

Royalty/License$935,513 (97.2%)
Consulting$25,723 (2.7%)
Travel$618.01 (0.1%)
Food & Beverage$474.62 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Royalty or License $935,513 25 97.2%
Consulting Fee $25,723 1 2.7%
Travel and Lodging $618.01 2 0.1%
Food and Beverage $474.62 8 0.0%
Unspecified $0 8 0.0%

Payments by Type

General
$962,328
36 transactions
Ownership
$0
8 transactions

Top Paying Companies

Company Total Records Latest Year
Abbott Laboratories $961,236 26 $0 (2024)
Relievant Medsystems, Inc. $837.40 5 $0 (2023)
Saluda Medical Americas, Inc. $219.05 2 $0 (2024)
Depomed, Inc. $22.67 2 $0 (2017)
Corcept Therapeutics $13.51 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $90,589 7 Abbott Laboratories ($90,370)
2023 $115,840 10 Abbott Laboratories ($115,003)
2022 $136,805 5 Abbott Laboratories ($136,805)
2021 $185,776 6 Abbott Laboratories ($185,776)
2020 $159,151 5 Abbott Laboratories ($159,151)
2019 $217,701 5 Abbott Laboratories ($217,701)
2018 $56,431 2 Abbott Laboratories ($56,431)
2017 $36.18 4 Depomed, Inc. ($22.67)

All Payment Transactions

44 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
11/21/2024 Saluda Medical Americas, Inc. Evoke (Device) Food and Beverage In-kind items and services $196.16 General
Category: Spinal Cord Stimulator
11/12/2024 Saluda Medical Americas, Inc. Evoke (Device) Food and Beverage In-kind items and services $22.89 General
Category: Spinal Cord Stimulator
10/16/2024 Abbott Laboratories Royalty or License Cash or cash equivalent $23,744.97 General
Category: Neuromodulation
07/17/2024 Abbott Laboratories Royalty or License Cash or cash equivalent $24,542.56 General
Category: Neuromodulation
04/17/2024 Abbott Laboratories Royalty or License Cash or cash equivalent $19,372.32 General
Category: Neuromodulation
01/17/2024 Abbott Laboratories Royalty or License Cash or cash equivalent $22,709.94 General
Category: Neuromodulation
2024 Spinal Surgical Strategies, Inc. $0.00 Ownership
10/18/2023 Abbott Laboratories Royalty or License Cash or cash equivalent $25,703.38 General
Category: Neuromodulation
07/12/2023 Abbott Laboratories Consulting Fee Cash or cash equivalent $25,723.25 General
Category: DIAGNOSTICS
04/19/2023 Abbott Laboratories Royalty or License Cash or cash equivalent $33,708.68 General
Category: Neuromodulation
02/15/2023 Relievant Medsystems, Inc. Intracept (Device), Intracept, Intracept Travel and Lodging Cash or cash equivalent $240.21 General
Category: Pain
02/15/2023 Relievant Medsystems, Inc. Intracept (Device), Intracept, Intracept Food and Beverage Cash or cash equivalent $150.00 General
Category: Pain
02/03/2023 Relievant Medsystems, Inc. Intracept (Device), Intracept, Intracept Food and Beverage Cash or cash equivalent $38.78 General
Category: Pain
02/03/2023 Relievant Medsystems, Inc. Intracept (Device), Intracept, Intracept Food and Beverage Cash or cash equivalent $30.61 General
Category: Pain
01/17/2023 Abbott Laboratories Royalty or License Cash or cash equivalent $29,867.50 General
Category: Neuromodulation
01/10/2023 Relievant Medsystems, Inc. Intracept (Device), Intracept, Intracept Travel and Lodging Cash or cash equivalent $377.80 General
Category: Pain
2023 Spinal Surgical Strategies, Inc. $0.00 Ownership
10/19/2022 Abbott Laboratories Royalty or License Cash or cash equivalent $33,760.70 General
Category: Neuromodulation
07/13/2022 Abbott Laboratories IONICRF (Device) Royalty or License Cash or cash equivalent $33,840.44 General
Category: Neuromodulation
04/13/2022 Abbott Laboratories IONICRF (Device) Royalty or License Cash or cash equivalent $34,795.86 General
Category: Neuromodulation
01/19/2022 Abbott Laboratories NT2000IX (Device) Royalty or License Cash or cash equivalent $34,407.80 General
Category: Neuromodulation
2022 Spinal Surgical Strategies, Inc. $0.00 Ownership
10/13/2021 Abbott Laboratories IonicRF Generator (Device) Royalty or License Cash or cash equivalent $36,922.82 General
Category: Neuromodulation
07/21/2021 Abbott Laboratories IonicRF Generator (Device) Royalty or License Cash or cash equivalent $37,420.80 General
Category: Neuromodulation
04/21/2021 Abbott Laboratories IonicRF Generator (Device) Royalty or License Cash or cash equivalent $34,914.21 General
Category: Neuromodulation

About Dr. Bradley Vilims, MD

Dr. Bradley Vilims, MD is a Pain Medicine healthcare provider based in Lakewood, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881664944.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bradley Vilims, MD has received a total of $962,328 in payments from pharmaceutical and medical device companies, with $90,589 received in 2024. These payments were reported across 44 transactions from 6 companies. The most common payment nature is "Royalty or License" ($935,513).

Practice Information

  • Specialty Pain Medicine
  • Other Specialties Interventional Pain Medicine
  • Location Lakewood, CO
  • Active Since 01/23/2006
  • Last Updated 10/03/2007
  • Taxonomy Code 207LP2900X
  • Entity Type Individual
  • NPI Number 1881664944

Products in Payments

  • IonicRF Generator (Device) $185,776
  • CRM-Research only (Device) $160,971
  • Cardiovascular- Research only (Device) $113,161
  • Neuromodulation Dspsbls and Accs (Device) $107,777
  • IONICRF (Device) $68,636
  • Cardiovascular-Research only (Device) $51,374
  • NT2000IX (Device) $34,408
  • Intracept (Device) $837.40
  • Evoke (Device) $219.05
  • Nucynta (Drug) $22.67
  • Korlym (Drug) $13.51

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pain Medicine Doctors in Lakewood